Global Rabies Vaccine Market Insights and Forecast to 2028

Q: Who are the key players in the rabies vaccine market?

Some of the key players are GSK (Novartis), Sanofi Pasteur, Chengda, Yisheng, Prcmise, VACN, Changsheng, BCHT, Hissen, GSK, Russia, Others.

Code: QYRE-Auto-34M23

Report

January 2022

88 Pages

QYResearch

Region: Global, Africa, China, Europe, North America, Asia, Central & South America, Middle East, Asia Pacific,

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

GSK (Novartis)

Sanofi Pasteur

Chengda

Yisheng

Prcmise

VACN

Changsheng

BCHT

Hissen

GSK

Russia

Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.

Market Analysis and Insights: Global Rabies Vaccine Market

Due to the COVID-19 pandemic, the global Rabies Vaccine market size is estimated to be worth US$ 971.4 million in 2022 and is forecast to a readjusted size of US$ 1229.1 million by 2028 with a CAGR of 4.0% during the review period.

Fully considering the economic change by this health crisis, Vero Cell Rabies Vaccine accounting for % of the Rabies Vaccine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Pre-exposure Prophylaxis segment is altered to an % CAGR throughout this forecast period.

Global Rabies Vaccine key players include Chengda, Changsheng, Prcmise, VACN, etc. Global top four manufacturers hold a share about 70%.

China is the largest market, with a share about 85%, followed by Europe, and North America, both have a share over 10 percent.

In terms of product, Vero Cell Rabies Vaccine is the largest segment, with a share over 75%. And in terms of application, the largest application is Post-exposure Prophylaxis, followed by Pre-exposure Prophylaxis.

Global Rabies Vaccine Scope and Segment

Rabies Vaccine market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Rabies Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Vero Cell Rabies Vaccine

BHK

Chick Embryo Cell Rabies Vaccine

Others

Segment by Application

Pre-exposure Prophylaxis

Post-exposure Prophylaxis

BY COMPANY

GSK (Novartis)

Sanofi-Pasteur

Chengda

Yisheng

Prcmise

VACN

Changsheng

BCHT

Hissen

BY REGION

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

FEATURED COMPANIES

GSK (Novartis)

Sanofi Pasteur

Chengda

Yisheng

Prcmise

VACN

Changsheng

BCHT

Hissen

GSK

Russia

1 Study Coverage

1.1 Rabies Vaccine Product Introduction

1.2 Market by Type

1.2.1 Global Rabies Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Vero Cell Rabies Vaccine

1.2.3 BHK

1.2.4 Chick Embryo Cell Rabies Vaccine

1.2.5 Others

1.3 Market by Application

1.3.1 Global Rabies Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Pre-exposure Prophylaxis

1.3.3 Post-exposure Prophylaxis

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Rabies Vaccine Sales Estimates and Forecasts 2017-2028

2.2 Global Rabies Vaccine Revenue Estimates and Forecasts 2017-2028

2.3 Global Rabies Vaccine Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Rabies Vaccine Sales by Region

2.4.1 Global Rabies Vaccine Sales by Region (2017-2022)

2.4.2 Global Sales Rabies Vaccine by Region (2023-2028)

2.5 Global Rabies Vaccine Revenue by Region

2.5.1 Global Rabies Vaccine Revenue by Region (2017-2022)

2.5.2 Global Rabies Vaccine Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Rabies Vaccine Sales by Manufacturers

3.1.1 Global Top Rabies Vaccine Manufacturers by Sales (2017-2022)

3.1.2 Global Rabies Vaccine Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Rabies Vaccine in 2021

3.2 Global Rabies Vaccine Revenue by Manufacturers

3.2.1 Global Rabies Vaccine Revenue by Manufacturers (2017-2022)

3.2.2 Global Rabies Vaccine Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Rabies Vaccine Revenue in 2021

3.3 Global Rabies Vaccine Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Rabies Vaccine Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Rabies Vaccine Sales by Type

4.1.1 Global Rabies Vaccine Historical Sales by Type (2017-2022)

4.1.2 Global Rabies Vaccine Forecasted Sales by Type (2023-2028)

4.1.3 Global Rabies Vaccine Sales Market Share by Type (2017-2028)

4.2 Global Rabies Vaccine Revenue by Type

4.2.1 Global Rabies Vaccine Historical Revenue by Type (2017-2022)

4.2.2 Global Rabies Vaccine Forecasted Revenue by Type (2023-2028)

4.2.3 Global Rabies Vaccine Revenue Market Share by Type (2017-2028)

4.3 Global Rabies Vaccine Price by Type

4.3.1 Global Rabies Vaccine Price by Type (2017-2022)

4.3.2 Global Rabies Vaccine Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Rabies Vaccine Sales by Application

5.1.1 Global Rabies Vaccine Historical Sales by Application (2017-2022)

5.1.2 Global Rabies Vaccine Forecasted Sales by Application (2023-2028)

5.1.3 Global Rabies Vaccine Sales Market Share by Application (2017-2028)

5.2 Global Rabies Vaccine Revenue by Application

5.2.1 Global Rabies Vaccine Historical Revenue by Application (2017-2022)

5.2.2 Global Rabies Vaccine Forecasted Revenue by Application (2023-2028)

5.2.3 Global Rabies Vaccine Revenue Market Share by Application (2017-2028)

5.3 Global Rabies Vaccine Price by Application

5.3.1 Global Rabies Vaccine Price by Application (2017-2022)

5.3.2 Global Rabies Vaccine Price Forecast by Application (2023-2028)

6 North America

6.1 North America Rabies Vaccine Market Size by Type

6.1.1 North America Rabies Vaccine Sales by Type (2017-2028)

6.1.2 North America Rabies Vaccine Revenue by Type (2017-2028)

6.2 North America Rabies Vaccine Market Size by Application

6.2.1 North America Rabies Vaccine Sales by Application (2017-2028)

6.2.2 North America Rabies Vaccine Revenue by Application (2017-2028)

6.3 North America Rabies Vaccine Market Size by Country

6.3.1 North America Rabies Vaccine Sales by Country (2017-2028)

6.3.2 North America Rabies Vaccine Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Rabies Vaccine Market Size by Type

7.1.1 Europe Rabies Vaccine Sales by Type (2017-2028)

7.1.2 Europe Rabies Vaccine Revenue by Type (2017-2028)

7.2 Europe Rabies Vaccine Market Size by Application

7.2.1 Europe Rabies Vaccine Sales by Application (2017-2028)

7.2.2 Europe Rabies Vaccine Revenue by Application (2017-2028)

7.3 Europe Rabies Vaccine Market Size by Country

7.3.1 Europe Rabies Vaccine Sales by Country (2017-2028)

7.3.2 Europe Rabies Vaccine Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Rabies Vaccine Market Size by Type

8.1.1 Asia Pacific Rabies Vaccine Sales by Type (2017-2028)

8.1.2 Asia Pacific Rabies Vaccine Revenue by Type (2017-2028)

8.2 Asia Pacific Rabies Vaccine Market Size by Application

8.2.1 Asia Pacific Rabies Vaccine Sales by Application (2017-2028)

8.2.2 Asia Pacific Rabies Vaccine Revenue by Application (2017-2028)

8.3 Asia Pacific Rabies Vaccine Market Size by Region

8.3.1 Asia Pacific Rabies Vaccine Sales by Region (2017-2028)

8.3.2 Asia Pacific Rabies Vaccine Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 China Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

9 Latin America

9.1 Latin America Rabies Vaccine Market Size by Type

9.1.1 Latin America Rabies Vaccine Sales by Type (2017-2028)

9.1.2 Latin America Rabies Vaccine Revenue by Type (2017-2028)

9.2 Latin America Rabies Vaccine Market Size by Application

9.2.1 Latin America Rabies Vaccine Sales by Application (2017-2028)

9.2.2 Latin America Rabies Vaccine Revenue by Application (2017-2028)

9.3 Latin America Rabies Vaccine Market Size by Country

9.3.1 Latin America Rabies Vaccine Sales by Country (2017-2028)

9.3.2 Latin America Rabies Vaccine Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Rabies Vaccine Market Size by Type

10.1.1 Middle East and Africa Rabies Vaccine Sales by Type (2017-2028)

10.1.2 Middle East and Africa Rabies Vaccine Revenue by Type (2017-2028)

10.2 Middle East and Africa Rabies Vaccine Market Size by Application

10.2.1 Middle East and Africa Rabies Vaccine Sales by Application (2017-2028)

10.2.2 Middle East and Africa Rabies Vaccine Revenue by Application (2017-2028)

10.3 Middle East and Africa Rabies Vaccine Market Size by Country

10.3.1 Middle East and Africa Rabies Vaccine Sales by Country (2017-2028)

10.3.2 Middle East and Africa Rabies Vaccine Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 GSK (Novartis)

11.1.1 GSK (Novartis) Corporation Information

11.1.2 GSK (Novartis) Overview

11.1.3 GSK (Novartis) Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 GSK (Novartis) Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 GSK (Novartis) Recent Developments

11.2 Sanofi-Pasteur

11.2.1 Sanofi-Pasteur Corporation Information

11.2.2 Sanofi-Pasteur Overview

11.2.3 Sanofi-Pasteur Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 Sanofi-Pasteur Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Sanofi-Pasteur Recent Developments

11.3 Chengda

11.3.1 Chengda Corporation Information

11.3.2 Chengda Overview

11.3.3 Chengda Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 Chengda Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Chengda Recent Developments

11.4 Yisheng

11.4.1 Yisheng Corporation Information

11.4.2 Yisheng Overview

11.4.3 Yisheng Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 Yisheng Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Yisheng Recent Developments

11.5 Prcmise

11.5.1 Prcmise Corporation Information

11.5.2 Prcmise Overview

11.5.3 Prcmise Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 Prcmise Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Prcmise Recent Developments

11.6 VACN

11.6.1 VACN Corporation Information

11.6.2 VACN Overview

11.6.3 VACN Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 VACN Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 VACN Recent Developments

11.7 Changsheng

11.7.1 Changsheng Corporation Information

11.7.2 Changsheng Overview

11.7.3 Changsheng Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 Changsheng Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Changsheng Recent Developments

11.8 BCHT

11.8.1 BCHT Corporation Information

11.8.2 BCHT Overview

11.8.3 BCHT Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)

11.8.4 BCHT Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 BCHT Recent Developments

11.9 Hissen

11.9.1 Hissen Corporation Information

11.9.2 Hissen Overview

11.9.3 Hissen Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)

11.9.4 Hissen Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Hissen Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Rabies Vaccine Industry Chain Analysis

12.2 Rabies Vaccine Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Rabies Vaccine Production Mode & Process

12.4 Rabies Vaccine Sales and Marketing

12.4.1 Rabies Vaccine Sales Channels

12.4.2 Rabies Vaccine Distributors

12.5 Rabies Vaccine Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Rabies Vaccine Industry Trends

13.2 Rabies Vaccine Market Drivers

13.3 Rabies Vaccine Market Challenges

13.4 Rabies Vaccine Market Restraints

14 Key Findings in The Global Rabies Vaccine Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

GSK (Novartis)

Sanofi Pasteur

Chengda

Yisheng

Prcmise

VACN

Changsheng

BCHT

Hissen

GSK

Russia

List of Tables

Table 1. Global Rabies Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)

Table 2. Major Manufacturers of Vero Cell Rabies Vaccine

Table 3. Major Manufacturers of BHK

Table 4. Major Manufacturers of Chick Embryo Cell Rabies Vaccine

Table 5. Major Manufacturers of Others

Table 6. Global Rabies Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)

Table 7. Global Rabies Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)

Table 8. Global Rabies Vaccine Sales by Region (2017-2022) & (K Units)

Table 9. Global Rabies Vaccine Sales Market Share by Region (2017-2022)

Table 10. Global Rabies Vaccine Sales by Region (2023-2028) & (K Units)

Table 11. Global Rabies Vaccine Sales Market Share by Region (2023-2028)

Table 12. Global Rabies Vaccine Revenue by Region (2017-2022) & (US$ Million)

Table 13. Global Rabies Vaccine Revenue Market Share by Region (2017-2022)

Table 14. Global Rabies Vaccine Revenue by Region (2023-2028) & (US$ Million)

Table 15. Global Rabies Vaccine Revenue Market Share by Region (2023-2028)

Table 16. Global Rabies Vaccine Sales by Manufacturers (2017-2022) & (K Units)

Table 17. Global Rabies Vaccine Sales Share by Manufacturers (2017-2022)

Table 18. Global Rabies Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)

Table 19. Global Rabies Vaccine Revenue Share by Manufacturers (2017-2022)

Table 20. Rabies Vaccine Price by Manufacturers (2017-2022) &(USD/Unit)

Table 21. Global Rabies Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 22. Global Rabies Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rabies Vaccine as of 2021)

Table 23. Rabies Vaccine Manufacturing Base Distribution and Headquarters

Table 24. Manufacturers Rabies Vaccine Product Offered

Table 25. Date of Manufacturers Enter into Rabies Vaccine Market

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Rabies Vaccine Sales by Type (2017-2022) & (K Units)

Table 28. Global Rabies Vaccine Sales by Type (2023-2028) & (K Units)

Table 29. Global Rabies Vaccine Sales Share by Type (2017-2022)

Table 30. Global Rabies Vaccine Sales Share by Type (2023-2028)

Table 31. Global Rabies Vaccine Revenue by Type (2017-2022) & (US$ Million)

Table 32. Global Rabies Vaccine Revenue by Type (2023-2028) & (US$ Million)

Table 33. Global Rabies Vaccine Revenue Share by Type (2017-2022)

Table 34. Global Rabies Vaccine Revenue Share by Type (2023-2028)

Table 35. Rabies Vaccine Price by Type (2017-2022) & (USD/Unit)

Table 36. Global Rabies Vaccine Price Forecast by Type (2023-2028) & (USD/Unit)

Table 37. Global Rabies Vaccine Sales by Application (2017-2022) & (K Units)

Table 38. Global Rabies Vaccine Sales by Application (2023-2028) & (K Units)

Table 39. Global Rabies Vaccine Sales Share by Application (2017-2022)

Table 40. Global Rabies Vaccine Sales Share by Application (2023-2028)

Table 41. Global Rabies Vaccine Revenue by Application (2017-2022) & (US$ Million)

Table 42. Global Rabies Vaccine Revenue by Application (2023-2028) & (US$ Million)

Table 43. Global Rabies Vaccine Revenue Share by Application (2017-2022)

Table 44. Global Rabies Vaccine Revenue Share by Application (2023-2028)

Table 45. Rabies Vaccine Price by Application (2017-2022) & (USD/Unit)

Table 46. Global Rabies Vaccine Price Forecast by Application (2023-2028) & (USD/Unit)

Table 47. North America Rabies Vaccine Sales by Type (2017-2022) & (K Units)

Table 48. North America Rabies Vaccine Sales by Type (2023-2028) & (K Units)

Table 49. North America Rabies Vaccine Revenue by Type (2017-2022) & (US$ Million)

Table 50. North America Rabies Vaccine Revenue by Type (2023-2028) & (US$ Million)

Table 51. North America Rabies Vaccine Sales by Application (2017-2022) & (K Units)

Table 52. North America Rabies Vaccine Sales by Application (2023-2028) & (K Units)

Table 53. North America Rabies Vaccine Revenue by Application (2017-2022) & (US$ Million)

Table 54. North America Rabies Vaccine Revenue by Application (2023-2028) & (US$ Million)

Table 55. North America Rabies Vaccine Sales by Country (2017-2022) & (K Units)

Table 56. North America Rabies Vaccine Sales by Country (2023-2028) & (K Units)

Table 57. North America Rabies Vaccine Revenue by Country (2017-2022) & (US$ Million)

Table 58. North America Rabies Vaccine Revenue by Country (2023-2028) & (US$ Million)

Table 59. Europe Rabies Vaccine Sales by Type (2017-2022) & (K Units)

Table 60. Europe Rabies Vaccine Sales by Type (2023-2028) & (K Units)

Table 61. Europe Rabies Vaccine Revenue by Type (2017-2022) & (US$ Million)

Table 62. Europe Rabies Vaccine Revenue by Type (2023-2028) & (US$ Million)

Table 63. Europe Rabies Vaccine Sales by Application (2017-2022) & (K Units)

Table 64. Europe Rabies Vaccine Sales by Application (2023-2028) & (K Units)

Table 65. Europe Rabies Vaccine Revenue by Application (2017-2022) & (US$ Million)

Table 66. Europe Rabies Vaccine Revenue by Application (2023-2028) & (US$ Million)

Table 67. Europe Rabies Vaccine Sales by Country (2017-2022) & (K Units)

Table 68. Europe Rabies Vaccine Sales by Country (2023-2028) & (K Units)

Table 69. Europe Rabies Vaccine Revenue by Country (2017-2022) & (US$ Million)

Table 70. Europe Rabies Vaccine Revenue by Country (2023-2028) & (US$ Million)

Table 71. Asia Pacific Rabies Vaccine Sales by Type (2017-2022) & (K Units)

Table 72. Asia Pacific Rabies Vaccine Sales by Type (2023-2028) & (K Units)

Table 73. Asia Pacific Rabies Vaccine Revenue by Type (2017-2022) & (US$ Million)

Table 74. Asia Pacific Rabies Vaccine Revenue by Type (2023-2028) & (US$ Million)

Table 75. Asia Pacific Rabies Vaccine Sales by Application (2017-2022) & (K Units)

Table 76. Asia Pacific Rabies Vaccine Sales by Application (2023-2028) & (K Units)

Table 77. Asia Pacific Rabies Vaccine Revenue by Application (2017-2022) & (US$ Million)

Table 78. Asia Pacific Rabies Vaccine Revenue by Application (2023-2028) & (US$ Million)

Table 79. Asia Pacific Rabies Vaccine Sales by Region (2017-2022) & (K Units)

Table 80. Asia Pacific Rabies Vaccine Sales by Region (2023-2028) & (K Units)

Table 81. Asia Pacific Rabies Vaccine Revenue by Region (2017-2022) & (US$ Million)

Table 82. Asia Pacific Rabies Vaccine Revenue by Region (2023-2028) & (US$ Million)

Table 83. Latin America Rabies Vaccine Sales by Type (2017-2022) & (K Units)

Table 84. Latin America Rabies Vaccine Sales by Type (2023-2028) & (K Units)

Table 85. Latin America Rabies Vaccine Revenue by Type (2017-2022) & (US$ Million)

Table 86. Latin America Rabies Vaccine Revenue by Type (2023-2028) & (US$ Million)

Table 87. Latin America Rabies Vaccine Sales by Application (2017-2022) & (K Units)

Table 88. Latin America Rabies Vaccine Sales by Application (2023-2028) & (K Units)

Table 89. Latin America Rabies Vaccine Revenue by Application (2017-2022) & (US$ Million)

Table 90. Latin America Rabies Vaccine Revenue by Application (2023-2028) & (US$ Million)

Table 91. Latin America Rabies Vaccine Sales by Country (2017-2022) & (K Units)

Table 92. Latin America Rabies Vaccine Sales by Country (2023-2028) & (K Units)

Table 93. Latin America Rabies Vaccine Revenue by Country (2017-2022) & (US$ Million)

Table 94. Latin America Rabies Vaccine Revenue by Country (2023-2028) & (US$ Million)

Table 95. Middle East and Africa Rabies Vaccine Sales by Type (2017-2022) & (K Units)

Table 96. Middle East and Africa Rabies Vaccine Sales by Type (2023-2028) & (K Units)

Table 97. Middle East and Africa Rabies Vaccine Revenue by Type (2017-2022) & (US$ Million)

Table 98. Middle East and Africa Rabies Vaccine Revenue by Type (2023-2028) & (US$ Million)

Table 99. Middle East and Africa Rabies Vaccine Sales by Application (2017-2022) & (K Units)

Table 100. Middle East and Africa Rabies Vaccine Sales by Application (2023-2028) & (K Units)

Table 101. Middle East and Africa Rabies Vaccine Revenue by Application (2017-2022) & (US$ Million)

Table 102. Middle East and Africa Rabies Vaccine Revenue by Application (2023-2028) & (US$ Million)

Table 103. Middle East and Africa Rabies Vaccine Sales by Country (2017-2022) & (K Units)

Table 104. Middle East and Africa Rabies Vaccine Sales by Country (2023-2028) & (K Units)

Table 105. Middle East and Africa Rabies Vaccine Revenue by Country (2017-2022) & (US$ Million)

Table 106. Middle East and Africa Rabies Vaccine Revenue by Country (2023-2028) & (US$ Million)

Table 107. GSK (Novartis) Corporation Information

Table 108. GSK (Novartis) Description and Major Businesses

Table 109. GSK (Novartis) Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 110. GSK (Novartis) Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. GSK (Novartis) Recent Developments

Table 112. Sanofi-Pasteur Corporation Information

Table 113. Sanofi-Pasteur Description and Major Businesses

Table 114. Sanofi-Pasteur Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 115. Sanofi-Pasteur Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. Sanofi-Pasteur Recent Developments

Table 117. Chengda Corporation Information

Table 118. Chengda Description and Major Businesses

Table 119. Chengda Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 120. Chengda Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. Chengda Recent Developments

Table 122. Yisheng Corporation Information

Table 123. Yisheng Description and Major Businesses

Table 124. Yisheng Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 125. Yisheng Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. Yisheng Recent Developments

Table 127. Prcmise Corporation Information

Table 128. Prcmise Description and Major Businesses

Table 129. Prcmise Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 130. Prcmise Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 131. Prcmise Recent Developments

Table 132. VACN Corporation Information

Table 133. VACN Description and Major Businesses

Table 134. VACN Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 135. VACN Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 136. VACN Recent Developments

Table 137. Changsheng Corporation Information

Table 138. Changsheng Description and Major Businesses

Table 139. Changsheng Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 140. Changsheng Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 141. Changsheng Recent Developments

Table 142. BCHT Corporation Information

Table 143. BCHT Description and Major Businesses

Table 144. BCHT Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 145. BCHT Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 146. BCHT Recent Developments

Table 147. Hissen Corporation Information

Table 148. Hissen Description and Major Businesses

Table 149. Hissen Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 150. Hissen Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 151. Hissen Recent Developments

Table 152. Key Raw Materials Lists

Table 153. Raw Materials Key Suppliers Lists

Table 154. Rabies Vaccine Distributors List

Table 155. Rabies Vaccine Customers List

Table 156. Rabies Vaccine Market Trends

Table 157. Rabies Vaccine Market Drivers

Table 158. Rabies Vaccine Market Challenges

Table 159. Rabies Vaccine Market Restraints

Table 160. Research Programs/Design for This Report

Table 161. Key Data Information from Secondary Sources

Table 162. Key Data Information from Primary Sources

List of Figures

Figure 1. Rabies Vaccine Product Picture

Figure 3. Global Rabies Vaccine Market Share by Type in 2021 & 2028

Figure 3. Vero Cell Rabies Vaccine Product Picture

Figure 4. BHK Product Picture

Figure 5. Chick Embryo Cell Rabies Vaccine Product Picture

Figure 6. Others Product Picture

Figure 7. Global Rabies Vaccine Market Share by Application in 2021 & 2028

Figure 8. Pre-exposure Prophylaxis

Figure 9. Post-exposure Prophylaxis

Figure 10. Rabies Vaccine Report Years Considered

Figure 11. Global Rabies Vaccine Sales 2017-2028 (K Units)

Figure 12. Global Rabies Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028

Figure 13. Global Rabies Vaccine Revenue 2017-2028 (US$ Million)

Figure 14. Global Rabies Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028

Figure 15. Global Rabies Vaccine Sales Market Share by Region (2017-2022)

Figure 16. Global Rabies Vaccine Sales Market Share by Region (2023-2028)

Figure 17. North America Rabies Vaccine Sales YoY (2017-2028) & (K Units)

Figure 18. North America Rabies Vaccine Revenue YoY (2017-2028) & (US$ Million)

Figure 19. Europe Rabies Vaccine Sales YoY (2017-2028) & (K Units)

Figure 20. Europe Rabies Vaccine Revenue YoY (2017-2028) & (US$ Million)

Figure 21. Asia-Pacific Rabies Vaccine Sales YoY (2017-2028) & (K Units)

Figure 22. Asia-Pacific Rabies Vaccine Revenue YoY (2017-2028) & (US$ Million)

Figure 23. Latin America Rabies Vaccine Sales YoY (2017-2028) & (K Units)

Figure 24. Latin America Rabies Vaccine Revenue YoY (2017-2028) & (US$ Million)

Figure 25. Middle East & Africa Rabies Vaccine Sales YoY (2017-2028) & (K Units)

Figure 26. Middle East & Africa Rabies Vaccine Revenue YoY (2017-2028) & (US$ Million)

Figure 27. The Rabies Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021

Figure 28. The Top 5 and 10 Largest Manufacturers of Rabies Vaccine in the World: Market Share by Rabies Vaccine Revenue in 2021

Figure 29. Global Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021

Figure 30. Global Rabies Vaccine Sales Market Share by Type (2017-2028)

Figure 31. Global Rabies Vaccine Revenue Market Share by Type (2017-2028)

Figure 32. Global Rabies Vaccine Sales Market Share by Application (2017-2028)

Figure 33. Global Rabies Vaccine Revenue Market Share by Application (2017-2028)

Figure 34. North America Rabies Vaccine Sales Market Share by Type (2017-2028)

Figure 35. North America Rabies Vaccine Revenue Market Share by Type (2017-2028)

Figure 36. North America Rabies Vaccine Sales Market Share by Application (2017-2028)

Figure 37. North America Rabies Vaccine Revenue Market Share by Application (2017-2028)

Figure 38. North America Rabies Vaccine Sales Share by Country (2017-2028)

Figure 39. North America Rabies Vaccine Revenue Share by Country (2017-2028)

Figure 40. U.S. Rabies Vaccine Revenue (2017-2028) & (US$ Million)

Figure 41. Canada Rabies Vaccine Revenue (2017-2028) & (US$ Million)

Figure 42. Europe Rabies Vaccine Sales Market Share by Type (2017-2028)

Figure 43. Europe Rabies Vaccine Revenue Market Share by Type (2017-2028)

Figure 44. Europe Rabies Vaccine Sales Market Share by Application (2017-2028)

Figure 45. Europe Rabies Vaccine Revenue Market Share by Application (2017-2028)

Figure 46. Europe Rabies Vaccine Sales Share by Country (2017-2028)

Figure 47. Europe Rabies Vaccine Revenue Share by Country (2017-2028)

Figure 48. Germany Rabies Vaccine Revenue (2017-2028) & (US$ Million)

Figure 49. France Rabies Vaccine Revenue (2017-2028) & (US$ Million)

Figure 50. U.K. Rabies Vaccine Revenue (2017-2028) & (US$ Million)

Figure 51. Italy Rabies Vaccine Revenue (2017-2028) & (US$ Million)

Figure 52. Russia Rabies Vaccine Revenue (2017-2028) & (US$ Million)

Figure 53. Asia Pacific Rabies Vaccine Sales Market Share by Type (2017-2028)

Figure 54. Asia Pacific Rabies Vaccine Revenue Market Share by Type (2017-2028)

Figure 55. Asia Pacific Rabies Vaccine Sales Market Share by Application (2017-2028)

Figure 56. Asia Pacific Rabies Vaccine Revenue Market Share by Application (2017-2028)

Figure 57. Asia Pacific Rabies Vaccine Sales Share by Region (2017-2028)

Figure 58. Asia Pacific Rabies Vaccine Revenue Share by Region (2017-2028)

Figure 59. China Rabies Vaccine Revenue (2017-2028) & (US$ Million)

Figure 60. Japan Rabies Vaccine Revenue (2017-2028) & (US$ Million)

Figure 61. South Korea Rabies Vaccine Revenue (2017-2028) & (US$ Million)

Figure 62. India Rabies Vaccine Revenue (2017-2028) & (US$ Million)

Figure 63. Australia Rabies Vaccine Revenue (2017-2028) & (US$ Million)

Figure 64. China Taiwan Rabies Vaccine Revenue (2017-2028) & (US$ Million)

Figure 65. Indonesia Rabies Vaccine Revenue (2017-2028) & (US$ Million)

Figure 66. Thailand Rabies Vaccine Revenue (2017-2028) & (US$ Million)

Figure 67. Malaysia Rabies Vaccine Revenue (2017-2028) & (US$ Million)

Figure 68. Latin America Rabies Vaccine Sales Market Share by Type (2017-2028)

Figure 69. Latin America Rabies Vaccine Revenue Market Share by Type (2017-2028)

Figure 70. Latin America Rabies Vaccine Sales Market Share by Application (2017-2028)

Figure 71. Latin America Rabies Vaccine Revenue Market Share by Application (2017-2028)

Figure 72. Latin America Rabies Vaccine Sales Share by Country (2017-2028)

Figure 73. Latin America Rabies Vaccine Revenue Share by Country (2017-2028)

Figure 74. Mexico Rabies Vaccine Revenue (2017-2028) & (US$ Million)

Figure 75. Brazil Rabies Vaccine Revenue (2017-2028) & (US$ Million)

Figure 76. Argentina Rabies Vaccine Revenue (2017-2028) & (US$ Million)

Figure 77. Middle East and Africa Rabies Vaccine Sales Market Share by Type (2017-2028)

Figure 78. Middle East and Africa Rabies Vaccine Revenue Market Share by Type (2017-2028)

Figure 79. Middle East and Africa Rabies Vaccine Sales Market Share by Application (2017-2028)

Figure 80. Middle East and Africa Rabies Vaccine Revenue Market Share by Application (2017-2028)

Figure 81. Middle East and Africa Rabies Vaccine Sales Share by Country (2017-2028)

Figure 82. Middle East and Africa Rabies Vaccine Revenue Share by Country (2017-2028)

Figure 83. Turkey Rabies Vaccine Revenue (2017-2028) & (US$ Million)

Figure 84. Saudi Arabia Rabies Vaccine Revenue (2017-2028) & (US$ Million)

Figure 85. UAE Rabies Vaccine Revenue (2017-2028) & (US$ Million)

Figure 86. Rabies Vaccine Value Chain

Figure 87. Rabies Vaccine Production Process

Figure 88. Channels of Distribution

Figure 89. Distributors Profiles

Figure 90. Bottom-up and Top-down Approaches for This Report

Figure 91. Data Triangulation

Figure 92. Key Executives Interviewed

REPORTS VIEWED RECENTLY

Global Rabies Vaccine Market Insights and Forecast to 2028

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Rabies Vaccine Market Insights and Forecast to 2028

Published Date: January 2022

Report Code: QYRE-Auto-34M23

Global Rabies Vaccine Market Insights and Forecast to 2028

Code: QYRE-Auto-34M23

Report

January 2022

88 Pages

QYResearch

Region: Global, Africa, China, Europe, North America, Asia, Central & South America, Middle East, Asia Pacific,

FEATURED COMPANIES

Global Rabies Vaccine key players include Chengda, Changsheng, Prcmise, VACN, etc. Global top four manufacturers hold a share about 70%.

Segment by Type

Segment by Application

BY COMPANY

BY REGION

FEATURED COMPANIES

FEATURED COMPANIES

REPORTS VIEWED RECENTLY

SELECT A FORMAT

Single User

Electronic (PDF)

$4900

Multi User

Electronic (PDF)

$7350

Enterprise User

Electronic (PDF)

$9800

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-8W11843

Thu Aug 11 00:00:00 UTC 2022

Add to Cart

120 Pages

Type: Report

Code: QYRE-Auto-5Y11620

Wed Aug 10 00:00:00 UTC 2022

Add to Cart

120 Pages

Type: Report

Code: QYRE-Auto-25G11469

Wed Aug 10 00:00:00 UTC 2022

Add to Cart

120 Pages

Type: Report

Code: QYRE-Auto-23K11342

Mon Aug 08 00:00:00 UTC 2022

Add to Cart

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions